Sight Sciences (SGHT) Competitors $2.52 +0.11 (+4.56%) Closing price 04:00 PM EasternExtended Trading$2.52 0.00 (0.00%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGHT vs. BBNX, NPCE, DCTH, SMLR, TCMD, CLPT, CVRX, LUNG, ZIMV, and SNWVShould you be buying Sight Sciences stock or one of its competitors? The main competitors of Sight Sciences include Beta Bionics (BBNX), NeuroPace (NPCE), Delcath Systems (DCTH), Semler Scientific (SMLR), Tactile Systems Technology (TCMD), ClearPoint Neuro (CLPT), CVRx (CVRX), Pulmonx (LUNG), ZimVie (ZIMV), and SANUWAVE Health (SNWV). These companies are all part of the "medical equipment" industry. Sight Sciences vs. Beta Bionics NeuroPace Delcath Systems Semler Scientific Tactile Systems Technology ClearPoint Neuro CVRx Pulmonx ZimVie SANUWAVE Health Beta Bionics (NASDAQ:BBNX) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, community ranking, risk, valuation, profitability, institutional ownership and earnings. Does the media prefer BBNX or SGHT? In the previous week, Sight Sciences had 5 more articles in the media than Beta Bionics. MarketBeat recorded 7 mentions for Sight Sciences and 2 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 0.96 beat Sight Sciences' score of 0.50 indicating that Beta Bionics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sight Sciences 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals have more ownership in BBNX or SGHT? 55.5% of Sight Sciences shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is BBNX or SGHT more profitable? Beta Bionics has a net margin of 0.00% compared to Sight Sciences' net margin of -63.30%. Beta Bionics' return on equity of 0.00% beat Sight Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Beta BionicsN/A N/A N/A Sight Sciences -63.30%-47.28%-32.72% Which has preferable earnings & valuation, BBNX or SGHT? Beta Bionics has higher earnings, but lower revenue than Sight Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$65.12M6.98N/AN/AN/ASight Sciences$79.87M1.62-$55.55M-$1.03-2.45 Does the MarketBeat Community prefer BBNX or SGHT? Sight Sciences received 14 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 66.67% of users gave Beta Bionics an outperform vote while only 29.85% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformBeta BionicsOutperform Votes666.67% Underperform Votes333.33% Sight SciencesOutperform Votes2029.85% Underperform Votes4770.15% Do analysts prefer BBNX or SGHT? Beta Bionics currently has a consensus target price of $24.83, suggesting a potential upside of 136.96%. Sight Sciences has a consensus target price of $3.83, suggesting a potential upside of 52.12%. Given Beta Bionics' stronger consensus rating and higher possible upside, research analysts plainly believe Beta Bionics is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 SummaryBeta Bionics beats Sight Sciences on 10 of the 15 factors compared between the two stocks. Remove Ads Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGHT vs. The Competition Export to ExcelMetricSight SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$129.36M$4.07B$5.33B$7.57BDividend YieldN/A39.50%5.11%4.32%P/E Ratio-2.4727.6321.7317.81Price / Sales1.6250.20379.2094.61Price / CashN/A51.0838.1534.64Price / Book1.025.826.464.00Net Income-$55.55M$67.09M$3.20B$247.23M7 Day Performance20.57%5.64%6.54%7.26%1 Month Performance-7.35%-3.20%-8.55%-6.26%1 Year Performance-54.43%14.87%10.33%-0.18% Sight Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGHTSight Sciences3.4147 of 5 stars$2.52+4.6%$3.83+52.1%-58.5%$129.36M$79.87M-2.47210BBNXBeta BionicsN/A$10.44+5.3%$24.83+137.9%N/A$452.56M$65.12M0.00294NPCENeuroPace3.0468 of 5 stars$12.30+0.6%$15.20+23.6%-21.0%$400.49M$79.91M-12.30170Short Interest ↑Gap DownDCTHDelcath Systems3.122 of 5 stars$10.91-0.9%$22.75+108.5%+134.1%$364.43M$37.21M-8.0860News CoveragePositive NewsGap DownSMLRSemler Scientific2.4165 of 5 stars$34.15+0.9%$71.00+107.9%+24.0%$327.74M$56.29M6.96120Short Interest ↑Positive NewsGap DownTCMDTactile Systems Technology3.2242 of 5 stars$13.33+1.1%$18.00+35.0%-9.3%$315.47M$292.98M19.04980News CoveragePositive NewsCLPTClearPoint Neuro2.0754 of 5 stars$10.95-0.7%$25.00+128.3%+98.6%$302.57M$31.39M-15.87110Gap DownCVRXCVRx1.8925 of 5 stars$11.54-1.5%$17.83+54.5%-62.1%$300.46M$51.29M-4.29160LUNGPulmonx2.7228 of 5 stars$6.60-2.4%$12.75+93.2%-31.4%$262.65M$83.79M-4.58250News CoveragePositive NewsZIMVZimVie2.5382 of 5 stars$9.34-1.4%$23.00+146.3%-40.6%$260.09M$449.75M-0.712,700Analyst RevisionSNWVSANUWAVE HealthN/A$30.18-1.6%N/AN/A$258.01M$32.63M-7.7440High Trading Volume Remove Ads Related Companies and Tools Related Companies BBNX Alternatives NPCE Alternatives DCTH Alternatives SMLR Alternatives TCMD Alternatives CLPT Alternatives CVRX Alternatives LUNG Alternatives ZIMV Alternatives SNWV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGHT) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SGHT Stock Free SGHT Stock Alerts